期刊文献+

GnRH拮抗剂方案对卵巢低反应患者的应用效果 被引量:2

Effect of GnRHant antagonist regimen on patients with ovarian low reaction
下载PDF
导出
摘要 目的比较拮抗剂方案与长方案在卵巢低反应妇女体外受精-胚胎移植(IVF-ET)助孕中的应用效果。方法回顾性分析卵巢低反应患者在实施IVF-ET助孕中采用拮抗剂(GnRH-ant)方案212个周期与采用长方案的189个周期的临床资料。比较2组患者使用促性腺激素(Gn)天数、Gn量、成熟卵子率、受精率、优质胚胎率、临床妊娠率、早期流产率等有无差异。结果拮抗剂组患者的Gn时间(7.22±0.85)d和用量(1540±7.56)IU,明显低于长方案组患者;拮抗剂组患者的成熟卵子率(87.14%)、受精率(79.92%)、新鲜移植临床妊娠率(34.48%)高于长方案组,但差异无统计学意义(P>0.05);拮抗剂组患者的早期流产率(30%)低于长方案组患者,差异亦无统计学意义(P>0.05)。结论对于卵巢低反应的患者选择拮抗剂方案可以有效地降低Gn使用天数和用量,可以获得与采用长方案IVF-ET助孕相似的临床妊娠结局。 Objective To study the application effect of long - term program and antagonist program in in - vitro fertilization (IVF) assisted pregnancy for poor ovarian response. Methods Retrospectively analyzed the clinical datum of 401 poor ovarian response women who received IVF assisted reproductive therapy. They were divided into two groups according to the treatment regimen, including the long -term program group ( 189 cases) and the antagonist group (212 cases). Embryology index of two groups of patients including the amount of Gn duration of oocytes retrieved (7.22 -0.85) were significantly different (P 〈0.05). Gn used and endometrial thick- ness were compared, as well as the outcome indexes ( amount of oocytes,pregnancy rate, ectopic pregnancy rate, abortion rate and other related indicators to cancel the cycle). Results At the end of treatment, the use of gonadotropin and the days of gonadotropin used in the antagonist regimen group were significantly shorter than that in the long -term regimen group, the differences were statistically significant (P 〈 0. 05). There was no significant difference between the two groups in terms of the number of oocytes retrieved and the fertilization rate ( P 〉 0.05 ). The incidence of ectopic pregnancy and miscarriage and cycle cancelling in long - term regimen grotip was significantly higher than that in antagonist regimen group (P 〈 0. 05 ). Conclusions In the treatment of IVF assisted ovulation in poor ovarian response, the use of antagonists make to improve promote pregnancy rate and decrease abortion rate,at the same time it can lighten the financial burden.
作者 金锐 包俊华 赵亚琼 唐大伟 刘芳 白刚 马文叶 任萌萌 JIN Rui;BAO Junhua;ZHAO Yaqiong;TANG Dawei;LIU Fang;BAI Gang;MA Wenye;REN Mengmeng(Maternal and Child Health Care hospital of Yinchuan, Yinchuan ,750001, China)
出处 《宁夏医学杂志》 CAS 2018年第4期331-333,共3页 Ningxia Medical Journal
关键词 GNRH拮抗剂 卵巢低反应 体外受精 GnRtt antagonist Low ovary reaction In vitro fertilization
  • 相关文献

参考文献6

二级参考文献52

  • 1田颖,张晓凤,杨鉴冰.浅谈中医对多囊卵巢综合征病机与辨治的认识[J].现代中医药,2006,26(6):42-44. 被引量:34
  • 2Arslan M, Boeca S, Mirkin S, et al. Controlled ovarian hyperstimulation protocols for in vitro fertilization:two decades of experience after the birth of Elizabeth Can'. Fertil Steril, 2005, 84:555-569.
  • 3Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod,2007, 22 : 2805-2813.
  • 4Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH antagonists in ovarian stimulation for IVF. Hum Repcod Update, 2006, 12:333-340.
  • 5Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome. FertilSteril,2004,81 : 19-25.
  • 6Borm G, Mannaerts B. Treatment with the gonadotrophin- releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod,2000,15 : 1490-1498.
  • 7European and Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod, 2001, 16:644-651.
  • 8Fluker M, Grifo J, Leader A, et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril,2001, 75:38-45.
  • 9Fauser BJM, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatrnent during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Sterile2005, 83:1607-1611.
  • 10Mochtar M. The effect of an individualized GnRH antagonist protocol in folliculogensis in IVF/ICSI. Hum Reprod, 2004, 19 : 1714-1718.

共引文献81

同被引文献15

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部